Mission
To strengthen Saudi Arabia's health sovereignty by manufacturing validated, internationally aligned molecular diagnostics in-Kingdom.
About
Building a national PCR diagnostics capability for the Kingdom.
Gene Matrix combines a regulated quality system, validated multiplex PCR science, and a clear strategic mandate — to localise critical diagnostics for Saudi Arabia and the wider region.
Vision
A leading regional source of clinically trusted PCR diagnostics — supporting clinicians, patients, and public-health response across the GCC and MENA.
Approach
A focused Phase 1 portfolio of four flagship multiplex PCR kits, manufactured under SFDA / ISO 13485 / WHO GMP-aligned quality systems.
Mission Pillars
Four pillars that guide everything we build
Our work is anchored by four operating commitments — translated daily into product, quality and partnership decisions.
- 1Manufacture validated multiplex PCR diagnostics in-Kingdom
- 2Operate to internationally recognised quality and regulatory standards
- 3Strengthen national health resilience and outbreak readiness
- 4Build a long-term centre of excellence for molecular diagnostics in Jeddah
Core Values
What we will and will not compromise on
Six values define how Gene Matrix operates — from the bench to the boardroom.
Scientific Integrity
Every assay validated to international references — no shortcuts on quality, performance or documentation.
National Sovereignty
Localising critical diagnostics to strengthen the Kingdom's resilience in cancer screening, sexual health and outbreak response.
Clinical Impact
Built around real diagnostic needs in Saudi clinical practice — not adapted from elsewhere.
Strategic Partnership
Long-term collaboration with hospitals, distributors, regulators and Vision 2030 programmes.
Innovation
A pipeline beyond Phase 1 — including next-generation sequencing and advanced platform capabilities.
Operational Excellence
GMP manufacturing, ISO 13485 quality systems and disciplined supply-chain operations.
Our Story
From a clinical conviction to a national capability
Gene Matrix was founded on a simple premise: a Kingdom of 35 million people should not depend entirely on imported diagnostics for cancer screening, sexual health, and outbreak response. From that conviction, a dedicated PCR manufacturer was built — anchored by a 700 m² GMP cleanroom, a regulated quality system, and a portfolio focused on the Kingdom's most pressing clinical priorities.
Read the full storyFounder
Dr. Burhan Fakhurji
Saudi biotechnology pioneer, academic, and serial entrepreneur with 20+ years in virology, molecular biology, genomics, and medical innovation. As Founder & CEO, Dr. Fakhurji leads Gene Matrix's scientific direction and its alignment with the Saudi Vision 2030 health-localisation agenda.
About the founder